Stomach Cancer: A Caregiver's Guide to Treatment Decisions

Stomach Cancer: A Caregiver's Guide to Treatment Decisions

When someone close to you has been diagnosed with stomach cancer, the decisions come fast and feel enormous. Surgery or chemotherapy first? Does the tumor qualify for newer targeted drugs? Can your loved one realistically travel for specialist care? If you are the one reading the reports, sitting in the appointments, and holding all the information together, this guide is written for you. It covers treatment options, biomarker testing, and when to seek a second opinion.

Stomach cancer - also called gastric cancer - is one of the more complex cancers to treat. The International Agency for Research on Cancer's GLOBOCAN 2024 estimates show that stomach cancer is the fifth most commonly diagnosed cancer worldwide, with close to 980,000 new cases recorded that year. The right treatment depends on factors specific to each patient: where in the stomach the tumor sits, how far it has spread, and what proteins are present on the cancer cells. Understanding those factors gives you the foundation to ask better questions and support a confident decision.

Oncologists are available through HealthUnwired for video consultations. Upload your loved one's pathology report and imaging, and a specialist can review it within 48 hours. No travel required.

Get Clear on the Stage First

Every major treatment decision for stomach cancer starts with staging. The stage describes how far the cancer has spread, using a scale from Stage I to Stage IV. Stage I tumors are limited to the inner layers of the stomach wall. Stage IV disease has reached distant organs such as the liver, lungs, or the lining of the abdomen. The National Cancer Institute notes that stage is one of the most important factors in choosing a treatment approach for stomach cancer.

If the staging report is still difficult to interpret, the article Stomach Cancer Diagnosis and Staging Explained breaks down each stage and explains what the findings on a pathology or imaging report typically mean for the road ahead.

One thing many caregivers do not know early on: staging is not always final after the first round of scans. Some oncology teams recommend a staging laparoscopy - a short surgical procedure that allows the surgeon to look directly inside the abdomen - to check for spread that a CT or PET-CT scan sometimes misses. Mayo Clinic notes that this step can help confirm whether the tumor is still removable before committing to a surgical plan. If this has not been mentioned, ask the team about it.

How Do the Main Stomach Cancer Treatments Compare?

Stomach cancer is rarely treated with a single method. Most patients get a combination of approaches, ordered by the tumor's stage and type. Below is a plain-language comparison of the three main treatment paths.

Sources: American Cancer Society - Treating Stomach Cancer; National Cancer Institute - Stomach Cancer Treatment.

The sequence matters as much as the combination. For many patients with Stage II or III disease, chemotherapy comes before surgery to shrink the tumor, then again after to reduce recurrence risk. When surgery is not an option - because the cancer has spread too far or the patient is not well enough - chemotherapy combined with targeted drugs or immunotherapy becomes the primary approach. The exact plan depends on the person's staging, fitness, and test results.

Why Biomarker Testing Matters Before Treatment Starts

Before treatment starts, the biopsy needs testing for two proteins: HER2 and PD-L1. These results can open drug options that would not otherwise be available. Caregivers often ask for a second opinion when they don't know whether the tumor was tested or what the results show.

HER2 is a protein that some stomach cancer cells make in excess. When a tumor tests HER2-positive, certain targeted drugs can be added to chemotherapy. The FDA has approved drug combinations for patients with HER2-positive advanced gastric cancer that pair a targeted drug with chemotherapy and an immunotherapy agent.

PD-L1 is a protein that affects how the immune system recognizes cancer cells. According to the American Cancer Society, doctors may add immunotherapy drugs to first-line treatment when a tumor has a PD-L1 Combined Positive Score of 1 or higher. The score is measured on the biopsy sample and determines whether an immune-based drug can be added to the treatment plan. Your oncologist or pathologist can explain what score was found and what it means for eligibility.

As a caregiver, it is reasonable and appropriate to ask directly whether the tumor has been tested for HER2 and PD-L1 and what those results showed. If the tests weren't ordered or the results weren't explained clearly, ask for a second review of the pathology before treatment starts.

Should You Seek a Second Opinion for Stomach Cancer?

For a diagnosis that depends on cancer stage and biomarker results, a second opinion is a normal and accepted part of cancer care. It is not a challenge to the treating doctor. Stomach cancer treatment typically needs a team - a surgical oncologist, a medical oncologist, and sometimes a gastroenterologist or radiation oncologist. A specialist at a high-volume centre can confirm the current plan, suggest a different order, find an untested biomarker, or spot a clinical trial the patient may join.

A second opinion is especially worth pursuing when:

• The cancer is Stage II or III and the surgical approach has not been clearly defined
• HER2 or PD-L1 tests were not done, or the results were not explained
• The team has said surgery is not possible and you want to understand why from another expert
• The patient is considering treatment at a different hospital or in another country
• The patient is too unwell to lead the research, leaving that role entirely to you

If your family member is seriously ill and cannot participate in medical conversations, the guide When Your Family Member Is Too Sick to Decide covers the steps for evaluating treatment options and arranging a second opinion when the patient cannot lead the process.

Questions to Ask at the Next Oncology Appointment

A short written list of questions helps you get the most from a limited appointment window. Bring it out at the start of the visit rather than waiting to see what time allows. As a caregiver making stomach cancer treatment decisions, consider asking:

• What stage is the cancer, and how confident is the team in that staging?
• Has the tumor been tested for HER2 and PD-L1? What were the results?
• Is surgery still an option, and where in the sequence does it happen?
• Will chemotherapy be given before surgery, after, or both?
• Are there any clinical trials this patient may qualify for right now?
• What is the primary goal of treatment at this stage - removing the cancer, slowing its growth, or controlling symptoms?
• Is a multidisciplinary tumour board reviewing this case?

Write the answers down or ask whether the appointment can be recorded. A second set of ears and a written record matter more than most people expect, especially when a treatment plan is still being built and the details change between visits.

Considering Treatment at a Specialist Centre or Abroad

Some families begin researching treatment centres in India or other countries when local waiting times are long, costs are difficult to manage, or the nearest hospital does not run a high-volume gastric surgery programme. Specialist centres in India that treat stomach cancer regularly offer costs that are substantially lower than in Western countries and have multidisciplinary oncology teams experienced with gastric cases. If you are weighing that option, the practical starting point is getting your loved one's medical records organised and in a format that international hospitals can review. The guide Getting Your Medical Records Ready for Treatment Abroad explains which documents to gather, how to get them translated if needed, and what formats most overseas hospitals request.

Caring for Yourself While You Care for Someone Else

Caregiving through a stomach cancer diagnosis often means sleep loss, worry, and the constant work of tracking appointments and results. Ignoring that load does not reduce it. It tends to build until it affects your ability to be present for the person who needs you. Practical steps like dividing tasks, keeping shared medical notes, and taking time to rest are not indulgences. They are part of staying effective across what may be a long treatment process. If sleep and stress are concerns, explore Ayurnomics's Sleep and Stress range with your care team. Always check any supplement with the patient's care team before use if there is any possibility of interaction with active cancer treatment.

To start, upload your loved one's reports to HealthUnwired to get a video consultation with a stomach cancer specialist within 48 hours - from home, at a time that suits your schedule. The consultation covers whether the diagnosis and proposed treatment align with current guidelines and what questions remain open before a final decision is made.

When to Talk to Your Doctor

Contact the care team if your loved one develops new symptoms before or during treatment - like trouble swallowing, unexpected weight loss, ongoing nausea, or new belly pain. Also raise any concerns about biomarker test results, the proposed sequence of treatments, or a wish to explore a second opinion. These are all appropriate conversations to initiate with the treating team, and a good oncologist will expect them.

This article is for general information and is not a substitute for medical advice. Always consult your oncologist or care team about your specific situation.